BUHLMANN Citations Archives - Page 9 of 14 - Buhlmann Diagnostics Corp

Category: BUHLMANN Citations

A number of the publications in the citation list describe applications that are outside of product claims thus they should be used for information only.

Proactive Therapeutic Drug Monitoring of Infliximab: A Comparative Study of a New Point-of-Care Quantitative Test with Two Established ELISA Assays

BÜHLMANN Quantum Blue® Infliximab Trough Level Assay Citation: Afonso J, Lopes S et al. Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays. Aliment Pharmacol Ther. 2016 Oct;44(7):684-92. doi: 10.1111/apt.13757. Epub 2016 Aug 10. PMID: 27507790 First Publication using our Quantum Blue® Infliximab Trough Level Assay We are very
Continue Reading

FOCUS: Future of Fecal Calprotectin Utility Study in Inflammatory Bowel Disease

BÜHLMANN Quantum Blue® fCAL Citation: Rosenfeld G, Greenup A-J, Round A, et al. FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease. World Journal of Gastroenterology. 2016;22(36):8211-8218. doi:10.3748/wjg.v22.i36.8211. PMID:27688663. Highlight from this Publication "The FC test effected a change in management 51.3% of the time and receipt of the result was associated with a reduction
Continue Reading

CAL-101, A p110delta Selective Phosphatidylinositol-3-Kinase Inhibitor for the Treatment of B-cell Malignancies, Inhibits PI3K Signaling and Cellular Viability

Flow CAST® - Kinase Inhibition Assay Citation: Lannutti, B.J. et al. CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood. 2011 Jan 13; 117(2): 591-594. PMID: 20959606. "We have thus described the biochemical and cellular activity of CAL-101, a selective and potent inhibitor of p110δ; such targeted
Continue Reading

A Novel Turbidimetric Immunoassay for Fecal Calprotectin Optimized for Routine Chemistry Analyzers

BÜHLMANN fCAL® turbo Citation: Nilsen, T. et. al.  A novel turbidimetric immunoassay for fecal calprotectin optimized for routine chemistry analyzers. J Clin Lab Anal. 2016 Sep 15. PMID:27629827 The publication describes the technical performance of the turbidimetric assay on the cobas c501 and the Mindray BS-380. Highlight from this Publication Short assay time of 10 min with
Continue Reading

High-Dose Rituximab and Anti-MAG-Associated Polyneuropathy

Anti-MAG Autoantibodies ELISA Citation: Renaud S et al.; High-dose rituximab and anti-MAG-associated polyneuropathy. Neurology. 2006 Mar 14; 66(5):742-4. PMID:16534115 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US. Health Canada License: 89118
Continue Reading

Anti-Myelin-Associated Glycoprotein Neuropathy

Anti-MAG Autoantibodies ELISA Citation: Steck AJ et al.; Anti-myelin-associated glycoprotein neuropathy; Curr Opin Neurol. 2006 Oct; 19(5): 458-63. Review. PMID:16969155 Read Citation Anti-MAG Autoantibodies ELISA  is for Research Use Only.  Not for use in diagnostic procedures in the US. Health Canada License: 89118
Continue Reading

Further Comparisons of Assays for Detecting MAG IgM Autoantibodies

Anti-MAG Autoantibodies ELISA Citation: Jaskowski TD et al.; Further comparisons of assays for detecting MAG IgM autoantibodies; J Neuroimmunol. 2007 Jul; 187(1-2): 175-8. PMID:17537521 Highlight from this Publication “EIA detected low titers of MAG IgM antibodies in suspected [subject] sera (negative by other methods) that were also SGPG IgM-positive.” Read Citation Anti-MAG Autoantibodies ELISA  is for Research Use
Continue Reading

Detection of Anti-MAG Antibodies in Polyneuropathy Associated with IgM Monoclonal Gammopathy

Anti-MAG Autoantibodies ELISA Citation: Kuijf ML et al.; Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy. Neurology. 2009 Sep 1; 73(9): 688-95. PMID:19720975 Highlights from this Publication “ In this study, the diagnostic accuracy of a new and more practical ELISA to detect these antibodies was validated...ELISA is more sensitive than Western blot..." Read
Continue Reading

Treatment with Rituximab in Patients with Polyneuropathy with Anti-MAG Antibodies

Anti-MAG Autoantibodies ELISA Citation: Delmont E et al.; Treatment with rituximab in patients with polyneuropathy with anti-MAG antibodies. J Neurol. 2011 Sep; 258(9):1717-9. PMID:21437663 Read Citation Anti-MAG Autoantibodies ELISA Citation: is for Research Use Only.  Not for use in diagnostic procedures in the US. Health Canada License: 89118
Continue Reading

Long-term Response to Rituximab and Fludarabine Combination in IgM Anti-Myelin-Associated Glycoprotein Neuropathy

Anti-MAG Autoantibodies ELISA Citation: Gruson B et al.; Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy. J Peripher Nerv Syst. 2011 Sep; 16(3): 180-5. PMID:22003932 Read Citation Anti-MAG Autoantibodies ELISA is for Research Use Only.  Not for use in diagnostic procedures in the US. Health Canada License: 89118
Continue Reading